The results are in agreement with Wang et al. in which E2 downregulated miR-27b in a leukemia cell line (Wang et al. 2014) and with Ye et al. in which VEGFC was shown to be a validated target of miR-27b in 293T and colorectal cancer cells (Ye et al. 2013). This evidence concerns the gene VEGFC and colorectal cancer.